Recently Viewed
Clear All
Bidding Date
04-Aug-2023 to
08-Aug-2023
Issue Size
₹1550.59 Cr
Price Band
₹705 to ₹741
Allotment date
11-Aug-2023
Listing date
18-Aug-2023
Lot size
20
No. of shares
2,09,25,652
Fresh issue/OFS
-- / ₹1550.59 Cr
No data found. Please visit the stock details page to know more about the company.
Read our in-depth analysis of the Concord Biotech Ltd IPO Here 
Category
Status
QIBs
67.7x
NIIs
17x
Retail
3.8x
Others
24.5x
Total
24.9x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Speciality Medicines | 117 - 124 | 20-Mar-2026 to 24-Mar-2026 |
| Central Mine Planning & Design Institute | 163 - 172 | 20-Mar-2026 to 24-Mar-2026 |
| Novus Loyalty | 139 - 146 | 17-Mar-2026 to 20-Mar-2026 |
| Highness Microelectronics | 114 - 120 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Concord Biotech is ₹1,550.59 Cr.
Concord Biotech falls into Pharmaceuticals industry.
The Concord Biotech IPO will be listed on both NSE and BSE.
The open and close dates for the Concord Biotech are 04-Aug-2023 & 08-Aug-2023.
The price band for the Concord Biotech ipo is ₹705 to ₹741
The listing date of Concord Biotech IPO is 18-Aug-2023.
The purpose of this IPO is to enable the existing shareholders to sell their stake.
Concord Biotech total subscription ratio is 24.9X.
Key financial of the Concord Biotech are:
| Concord Biotech | FY-23 | FY-22 | FY-21 |
|---|---|---|---|
| Revenue (₹ Cr) | 853.17 | 712.93 | 616.94 |
| EBIT (₹ Cr) | 294.55 | 223.88 | 300.41 |
| Proft after Tax (₹ Cr) | 240.09 | 174.93 | 234.89 |
| Debt (₹ Cr) | 31.24 | 60.59 | 86.35 |
| Net Worth (₹ Cr) | 1290 | 1103.22 | 999.37 |
| RoE (%) | 18.61 | 15.86 | 23.5 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
